This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Mycoplasmoides gallisepticum PvpA (pvpA), GST
Product Overview
BioVenic's Recombinant Mycoplasmoides gallisepticum PvpA (pvpA), GST is a recombinant protein expressed from E.coli. Its predicted molecular weight is 55.3 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
Mycoplasmoides gallisepticum PvpA (pvpA) is an important surface protein with immunogenicity and adhesion functions. In veterinary medicine, PvpA protein is mainly used for diagnosis, vaccine development, and research on pathogenesis. PvpA protein can serve as a diagnostic antigen for detecting Mycoplasma gallisepticum infection, and its immunogenicity makes it a potential candidate for developing subunit vaccines. Additionally, PvpA protein is involved in the adhesion of the pathogen to host cells, contributing to colonization and pathogenesis in the respiratory tract. Studies have shown that the expression and variation of PvpA protein may affect the pathogenicity and immune evasion of the pathogen, providing an important theoretical basis for the prevention and control of Mycoplasma gallisepticum infection.
Shipping and Storage
This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.